Skip to content

Advertisement

BMC Cancer

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Prediction of survival after neoadjuvant chemotherapy for breast cancer by evaluation of tumor-infiltrating lymphocytes and residual cancer burden

  • Yuka Asano1,
  • Shinichiro Kashiwagi1Email authorView ORCID ID profile,
  • Wataru Goto1,
  • Koji Takada1,
  • Katsuyuki Takahashi2,
  • Takaharu Hatano3,
  • Satoru Noda1,
  • Tsutomu Takashima1,
  • Naoyoshi Onoda1,
  • Shuhei Tomita2,
  • Hisashi Motomura3,
  • Masahiko Ohsawa4,
  • Kosei Hirakawa1 and
  • Masaichi Ohira1
BMC Cancer201717:888

https://doi.org/10.1186/s12885-017-3927-8

Received: 9 June 2017

Accepted: 14 December 2017

Published: 28 December 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
9 Jun 2017 Submitted Original manuscript
7 Aug 2017 Reviewed Reviewer Report - Nan Li
13 Aug 2017 Reviewed Reviewer Report - Chang Gong
16 Aug 2017 Reviewed Reviewer Report - Yan Nie
15 Oct 2017 Author responded Author comments - Yuka Asano
Resubmission - Version 2
15 Oct 2017 Submitted Manuscript version 2
1 Nov 2017 Reviewed Reviewer Report - Chang Gong
13 Nov 2017 Reviewed Reviewer Report - Yang Yu
21 Nov 2017 Author responded Author comments - Yuka Asano
Resubmission - Version 3
21 Nov 2017 Submitted Manuscript version 3
12 Dec 2017 Author responded Author comments - Yuka Asano
Resubmission - Version 4
12 Dec 2017 Submitted Manuscript version 4
Publishing
14 Dec 2017 Editorially accepted
28 Dec 2017 Article published 10.1186/s12885-017-3927-8

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Surgical Oncology, Osaka, Japan
(2)
Department of Pharmacology, Osaka, Japan
(3)
Department of Plastic and Reconstructive Surgery, Osaka, Japan
(4)
Department of Diagnostic Pathology, Osaka City University Graduate School of Medicine, Osaka, Japan

Advertisement